Molecular Cytomegalovirus
Refined in 2022 to use liquid plasma for a closer representation of real samples, the Molecular Cytomegalovirus Program addresses the critical challenge of standardising CMV viral load reporting. By identifying variations in testing methods and assay standards, this program educates participants and drives progress toward achieving consistency in diagnostic practices, ensuring reliability and accuracy in CMV DNA testing.